Quality of Life — Measuring and Mapping Cognitive Decline After Brain Radiosurgery
Citation(s)
Baldo JV, Schwartz S, Wilkins D, Dronkers NF Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc. 2006 Nov;12(6):896-900. doi: 10.1017/S1355617706061078.
DeMarco AT, Turkeltaub PE A multivariate lesion symptom mapping toolbox and examination of lesion-volume biases and correction methods in lesion-symptom mapping. Hum Brain Mapp. 2018 Nov;39(11):4169-4182. doi: 10.1002/hbm.24289. Epub 2018 Jul 4.
Geva S, Baron JC, Jones PS, Price CJ, Warburton EA A comparison of VLSM and VBM in a cohort of patients with post-stroke aphasia. Neuroimage Clin. 2012 Aug 30;1(1):37-47. doi: 10.1016/j.nicl.2012.08.003. eCollection 2012.
Olson RA, Chhanabhai T, McKenzie M Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Support Care Cancer. 2008 Nov;16(11):1273-8. doi: 10.1007/s00520-008-0431-3. Epub 2008 Mar 12.
Olson RA, Iverson GL, Carolan H, Parkinson M, Brooks BL, McKenzie M Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life. J Neurooncol. 2011 Nov;105(2):337-44. doi: 10.1007/s11060-011-0595-4. Epub 2011 Apr 26.
Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Vichare A, Hahn C, Chang EL International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. Clin Oncol (R Coll Radiol). 2012 Aug;24(6):e81-92. doi: 10.1016/j.clon.2012.03.008.
Yang Y, Tompkins CA, Meigh KM, Prat CS Voxel-Based Lesion Symptom Mapping of Coarse Coding and Suppression Deficits in Patients With Right Hemisphere Damage. Am J Speech Lang Pathol. 2015 Nov;24(4):S939-52. doi: 10.1044/2015_AJSLP-14-0149.
Measuring and Mapping Cognitive Decline After Brain Radiosurgery: a Pilot Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.